Jyong Biotech Ltd. SEC filings MENS
Jyong Biotech Ltd. has 73 filings in SEC EDGAR's recent list, going back to Mar 16, 2023. Its latest annual report, Form 20-F, was filed on May 15, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Feb 6, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D | Ownership over 5% (active) | Apr 24, 2026 | — |
| 3 | Initial insider ownership | Apr 14, 2026 | Apr 13, 2026 |
| 3 | Initial insider ownership | Apr 8, 2026 | Apr 8, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MENS (Nasdaq)
- Incorporated in
- Cayman Islands
- Headquarters
- New Taipei City
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1954488
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.